The Company is a healthcare solution provider dedicated to the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
The Company focuses on enhancing ability to attract, incentivize and maintain good relationships with talented professionals. The Company believes its success greatly depends on the ability to attract, incentivize and maintain long-term relationships with talented professionals. In addition, the Company aims to keep long-term relationships with third-party development teams or experts.
The Company continues to invest in research and development. The Company attributes part of its success to our continued investment in and focus on R&D.
The Company offers personalized and inclusive services that catered to the specific requirements of its clients.
我们是一家医疗解决方案提供商,致力于开发和商业化专门用于放射性粒籽植入的近距离治疗计划软件,粒籽植入治疗一种通过在患者体内放置放射源来杀死癌细胞和缩小肿瘤的治疗癌症患者的放射疗法。
公司注重提高吸引、激励人才并与之保持良好关系的能力。公司相信其成功在很大程度上取决于吸引、激励和保持与有才能的专业人士的长期关系的能力。此外,公司旨在与第三方开发团队或专家保持长期合作关系。
公司持续投资研究开发。公司的成功部分归功于其对研发的持续投资和专注。
公司提供根据客户的具体要求提供个性化和包容性的服务。